# Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediatric Population

> **NCT01191112** · PHASE3 · COMPLETED · sponsor: **Abbott Nutrition** · enrollment: 27 (actual)

## Conditions studied

- Gastrointestinal Diseases
- Feeding Intolerance

## Interventions

- **OTHER:** Peptide based enteral formula

## Key facts

- **NCT ID:** NCT01191112
- **Lead sponsor:** Abbott Nutrition
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2015-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01191112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01191112, "Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediatric Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01191112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*